Intravenous versus subcutaneous immunoglobulin - Authors' reply.
Publication
, Journal Article
van Schaik, IN; Mielke, O; PATH study group,
Published in: Lancet Neurol
May 2018
Duke Scholars
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
May 2018
Volume
17
Issue
5
Start / End Page
393 / 394
Location
England
Related Subject Headings
- Neurology & Neurosurgery
- Immunoglobulins, Intravenous
- Administration, Intravenous
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
van Schaik, I. N., Mielke, O., & PATH study group, . (2018). Intravenous versus subcutaneous immunoglobulin - Authors' reply. Lancet Neurol, 17(5), 393–394. https://doi.org/10.1016/S1474-4422(18)30109-1
Schaik, Ivo N. van, Orell Mielke, and Orell PATH study group. “Intravenous versus subcutaneous immunoglobulin - Authors' reply.” Lancet Neurol 17, no. 5 (May 2018): 393–94. https://doi.org/10.1016/S1474-4422(18)30109-1.
van Schaik IN, Mielke O, PATH study group. Intravenous versus subcutaneous immunoglobulin - Authors' reply. Lancet Neurol. 2018 May;17(5):393–4.
van Schaik, Ivo N., et al. “Intravenous versus subcutaneous immunoglobulin - Authors' reply.” Lancet Neurol, vol. 17, no. 5, May 2018, pp. 393–94. Pubmed, doi:10.1016/S1474-4422(18)30109-1.
van Schaik IN, Mielke O, PATH study group. Intravenous versus subcutaneous immunoglobulin - Authors' reply. Lancet Neurol. 2018 May;17(5):393–394.
Published In
Lancet Neurol
DOI
EISSN
1474-4465
Publication Date
May 2018
Volume
17
Issue
5
Start / End Page
393 / 394
Location
England
Related Subject Headings
- Neurology & Neurosurgery
- Immunoglobulins, Intravenous
- Administration, Intravenous
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences